A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia.

Fiedler, Walter; Mesters, Rolf; Tinnefeld, Heike; Loges, Sonja; Staib, Peter; Duhrsen, Ulrich; Flasshove, Michael; Ottmann, Oliver G; Jung, Wolfram; Cavalli, Franco; Kuse, Rolf; Thomalla, Joerg; Serve, Hubert; O'Farrell, Anne M; Jacobs, Mark; Brega, Nicoletta M; Scigalla, Paul; Hossfeld, Dieter K; Berdel, Wolfgang E

Fiedler, Walter; Mesters, Rolf; Tinnefeld, Heike; Loges, Sonja; Staib, Peter; Duhrsen, Ulrich; Flasshove, Michael; Ottmann, Oliver G; Jung, Wolfram; Cavalli, Franco; Kuse, Rolf; Thomalla, Joerg; Serve, Hubert; O'Farrell, Anne M; Jacobs, Mark; Brega, Nicoletta M; Scigalla, Paul; Hossfeld, Dieter K; Berdel, Wolfgang E.

Affiliation

Fiedler W; Department of Oncology/Hematology, University Hospital Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany. fiedler@uke.uni-hamburg.de

Blood ; 102(8): 2763-7, 2003 Oct 15.

Article in En | MEDLINE | ID: mdl-12843001

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Indoles/therapeutic use; Leukemia, Myeloid, Acute/drug therapy; Pyrroles/therapeutic use; Adult; Aged; Bone Marrow/metabolism; Cell Separation; Enzyme Inhibitors/therapeutic use; Female; Flow Cytometry; Humans; Male; Membrane Proteins/genetics; Microcirculation; Middle Aged; Mutation; Polymerase Chain Reaction; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor A/metabolism

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Leukemia, Myeloid, Acute / Angiogenesis Inhibitors / Indoles Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2003 Type: Article Affiliation country: Germany

Search on Google

XML

PubMed Links